| Date | Form | Description | Docs | XBRL | Pages |
| 07/21/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 07/15/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 07/14/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/06/25 | SCHEDULE 13D/A | General Statement of Acquisition of Beneficial Ownership |
|
3 | |
| 06/05/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 05/28/25 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
|
|
19 |
| 03/21/25 | 8-K | Current report |
|
|
21 |
| 03/11/25 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
|
|
17 |
| 02/06/25 | DEF 14A | Definitive proxy statements |
|
|
20 |
| 01/29/25 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
Latest News & Events
Anixa Biosciences Receives Notice of Allowance from Canadian Intellectual Property Office for Patent Covering Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Awarded New U.S. Patent Extending Breast Cancer Vaccine IP Protection into 2040s
Read More...Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology
Read More...